عنوان

Facts and hopes in thrombolysis in acute myocardial infarction.

3662071746

9783662071748

b579758

Facts and hopes in thrombolysis in acute myocardial infarction.

[Book]

[Place of publication not identified]

Steinkopff Darmstadt

2013

The role of ATP depletion and accumulated metabolic products during myocardial ischemia.- Ultrastructural aspects of ischemia and reperfusion in canine and human hearts.- Pro-urokinase and tissue-type plasminogen activator.- Preliminary clinical results with pro-urokinase.- Anisoylated streptokinase plasminogen activator.- Antifibrin-urokinase complex.- GISSI - A randomized trial with intravenous streptokinase in acute myocardial infarction. Preliminary results.- ISAM - A randomized trial with intravenous streptokinase versus placebo.- Randomized trial with intracoronary streptokinase versus placebo (Western Washington).- Randomized trial with intracoronary streptokinase versus placebo (The Netherlands).- Randomised trial with intravenous acylated streptokinase (BRL 26921) versus streptokinase (preliminary data).- Short and long term results with intracoronary SK with regard to further treatment and age of patients - experiences in Aachen-.- ECG and ECG mapping in myocardial infarction: facilities and limitations for assessment of coronary reperfusion therapy.- Measurement of improvement of left ventricular function after reperfusion using left ventricular angiography.- Quantitative assessment of regional left ventricular motion after early thrombolysis using endocardial landmarks.- Positron emission tomography of the heart.- Planar and tomographic scintigraphic studies in connection with coronary thrombolysis.- Echocardiography in myocardial infarction.- How to estimate reocclusion risk?.- Indications for early PTCA after thrombolysis.- Panel Discussion.- Clinical experience with rt-PA in the Cooperative European Trials. 1. rt-PA versus placebo.- Clinical experience with rt-PA in the Cooperative European Trials. 2. rt-PA versus streptokinase.- Panel Discussion.- What have we learned during this symposium?.- What shall we recommend to the practising physican and the cardiologist in a general hospital?.- What should the health services and regulatory agencies take into account?.- rt-PA - does this now mean thrombolysis for everyone?.- What should be the future strategy?.- A short overview summarizing two important rt-PA studies from the United States.

[Book]

Y